Efficacy and Safety of Vildagliptin 50mg Bid as an add-on Therapy to Insulin With or Without Metformin, in Patients With Type 2 Diabetes Mellitus
Clinical trial NCT01582230 · COMPLETED
Trial details
- NCT number
- NCT01582230
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2013-05-01
- Enrollment
- 293
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.